We targeted inflammatory S100A proteins and their regulation by inflammatory cytokines mediated by JAK2-STAT, PI3K-AKT, and NF-κB signaling pathways in patients with CLL. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.